I am a
Home I AM A Search Login

Papers of the Week


Int J Gen Med


Impact of Systemic Diseases on Olfactory Function in COVID-19 Infected Patients.


Awwad AA, Abd Elhay OMM, Rabie MM, Awad EA, Kotb FM, Maghraby HM, Eldamarawy RH, Dawood YMA, Balat MIEI, Hasan AIM, Elsheshiny AH, El Sayed SSMM, Fouda AAB, Alkot AMF
Int J Gen Med. 2022; 15:5681-5691.
PMID: 35747780.


COVID-19 (SARS-CoV-2/2019-nCoV) is now a major public health threat to the world. Olfactory dysfunctions (ODs) are considered potential indicating symptoms and early case identification triaging for coronavirus disease 2019 (COVID-19). The most common reported comorbidities are diabetes mellitus, chronic lung disease, and cardiovascular disease. The objective of this study was to evaluate prevalence of different types of smell disorders in patients with laboratory-confirmed COVID-19 infection and impact of involved systemic diseases.